Telangana: BioAsia to be held in Hyderabad from Feb 26

Hyderabad: The 21st Edition of BioAsia – Asia’s largest life-sciences and Health Tech forum and the annual flagship event of the Government of Telangana, will be at the Hyderabad International Convention Center (HICC) HICC here between February 26 – 28, 2024.

Telangana IT and Industries Minister Duddilla Sridhar Babu conducted a comprehensive review of the preparations for the coming global conference here on Thursday.

As the Flagship event of the Government of Telangana, BioAsia has emerged as a pivotal player in steering the life-sciences development journey in India, playing a crucial role in redirecting focus towards the advancements and challenges within the industry.

The 3-day Global conference is projected to attract over 3,000 participants from over 50 countries, and has already received significant registrations while the event is still 7 weeks away, a release said here. Around 200 companies have registered for the exhibition to showcase groundbreaking advancements and cutting-edge technologies in healthcare.

The 21st edition of BioAsia will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and will explore the theme of Data & AI: Redefining Possibilities, to deliberate the possibility of reshaping the future of healthtech delivery paradigm in the country.

The event boasts a lineup of 70 plus influential speakers, including global CEOs and industry leaders.
Besides, the Keynote speakers already announced for the event including David Ricks (CEO, Eli Lilly and Company), Dr. Christopher Boerner (Incoming CEO, Bristol Myers Squibb), Geoff Martha (Chairman and CEO, Medtronic), Prof. Gregg Semenza (Nobel Laureate & Professor at Johns Hopkins School of Medicine), among others for the event along with the string lineup of eminent Indian leaders.

The event will also feature President and CEO, Olympus Stefan Kaufmann; CEO of Providence Dr. Rod Hochman, M.D., Global Operating Partner of Advent International Stefan Stoffel, among others.

The event will provide a fertile ground for knowledge exchange and innovation in the life sciences and biotechnology sector. BioAsia 2024 will also offer a worldwide platform for promising startups in the pharmaceutical, biotech, life sciences, health-tech, and med-tech sectors to showcase their inventive concepts.

Speaking on the occasion, Sridhar Babu stated, ‘BioAsia has emerged as a critical instrument for the development of the Indian and global Life-Sciences and allied industries over the last two decades. We are thrilled to announce that several global CEOs will be attending BioAsia for the first time, underlining the event’s rising prominence on the international stage”.

Telangana Principal Secretary (IT & Industries) Jayesh Ranjan, said ‘Over the past 20 editions, BioAsia has played an unmatched role in sparking the renewed emphasis on the life-sciences industry, rekindling attention from regulation, corporates, startups and allied sectors alike’.

“21st edition of BioAsia is certainly going to be a milestone event, as the presence of global leaders marks the vision to bridge the gaps in the healthcare industry and foster innovation in these critical sectors” said Shakthi Nagappan, Director of Life Sciences, Government of Telangana and CEO of BioAsia.

The event, with EY as the knowledge partner, will focus on the themes including Transformative innovation –R&D, Patent Paradox: India’s Bid for Global R&D Dominance & IP Dilemmas, Leading the Health-tech revolution -The Next Normal, India at the frontier of Pharma Services, MedTech is the place to be that are pertinent to the industry in the current times.